Key result
Computational and animal models highlight emerging therapeutic strategies for pulmonary vein stenosis.
Why the study?
Pulmonary vein stenosis survival remains low despite advances, pushing experimental research into new medical therapies to prevent progression and recurrence.
This review summarizes current and experimental medical therapies for pulmonary vein stenosis derived from computational and animal modeling.
May inform future trials of medical therapies for pulmonary vein stenosis; leaves open clinical translation pending prospective studies.
Pulmonary vein stenosis (PVS) is a severe vascular obstructive lesion historically associated with poor survival. As outcomes have improved in the current era, PVS has become a chronic disease requiring frequent surgeries, catheter-based interventions, and experimental therapies to prevent progression and recurrence. Despite this, PVS survival remains low and has pushed experimental research into new therapies into the forefront. In this paper, we briefly examine the pathophysiology and etiology of PVS and provide a more comprehensive review of computational and animal modeling of PVS and therapies derived from these studies, both current and on the horizon.
No takes yet. Share an insight, caveat, or question.
Gupta et al. (2026) conducted a review in Pulmonary vein stenosis. Medical therapy was evaluated. This review examines the pathophysiology of pulmonary vein stenosis and highlights current and emerging therapies derived from computational and animal modeling.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: